Journal
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 313, Issue 3, Pages H584-H596Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpheart.00103.2017
Keywords
fatty acids; deoxyribonucleotide; metabolism; peroxisome proliferator-activated; receptor-alpha
Funding
- Nora Eccles Treadwell Foundation
- American Heart Association [17GRNT33440031]
- New Jersey Health Foundation Research Grant
- National Institutes of Health [HL-67724, HL-91469, HL-102738, HL-112330, AG-23039]
- Leducq Foundation Transatlantic Networks of Excellence
Ask authors/readers for more resources
Studies using omicsbased approaches have advanced our knowledge of metabolic remodeling in cardiac hypertrophy and failure. Metabolomic analysis of the failing heart has revealed global changes in mitochondrial substrate metabolism. Peroxisome proliferator-activated receptor-alpha (PPAR alpha) plays a critical role in synergistic regulation of cardiac metabolism through transcriptional control. Metabolic reprogramming via PPAR alpha signaling in heart failure ultimately propagates into myocardial energetics. However, emerging evidence suggests that the expression level of PPAR alpha per se does not always explain the energetic state in the heart. The transcriptional activities of PPAR alpha are dynamic, yet highly coordinated. An additional level of complexity in the PPAR alpha regulatory mechanism arises from its ability to interact with various partners, which ultimately determines the metabolic phenotype of the diseased heart. This review summarizes our current knowledge of the PPAR alpha regulatory mechanisms in cardiac metabolism and the possible role of PPAR alpha in epigenetic modifications in the diseased heart. In addition, we discuss how metabolomics can contribute to a better understanding of the role of PPAR alpha in the progression of cardiac hypertrophy and failure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available